Enhanced Absorption Of Therapeutic Material Internally Using Iontophoretic Treatment Patents (Class 604/501)
-
Patent number: 7123957Abstract: A device for ablating the stratum corneum epidermidis of a subject, including a plurality of electrodes, which are applied to the subject's skin at respective points. A power source applies electrical energy between two or more of the plurality of electrodes, in order to cause ablation of the stratum corneum primarily in an area intermediate the respective points.Type: GrantFiled: February 3, 2004Date of Patent: October 17, 2006Assignee: Transpharma Medical Ltd.Inventor: Zohar Avrahami
-
Patent number: 7069073Abstract: An electrokinetic delivery or diagnostic device for personal use and self-administration of a medicament to a treatment site is provided. The device includes a housing containing a power supply, a first active electrode and a ground tactile electrode. An applicator includes a pad for containing medicament for overlying the first electrode of the device. The medicament may be applied by the user to the pad, contained within the pad or contained in rupturable capsules within the pad, together with a hydrogel if necessary for imparting electrical conductivity whereby, upon application of the applicator to the treatment site, the medicament is electrokinetically transported into the treatment site.Type: GrantFiled: March 24, 2004Date of Patent: June 27, 2006Assignee: BioPhoretic Therapeutic Systems, LLCInventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg, Christopher H. Porter, V. Lorenzo Porcelli
-
Patent number: 7054683Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: GrantFiled: August 29, 2005Date of Patent: May 30, 2006Assignee: Alza CorporationInventors: Joseph B. Phipps, Gary A. Lattin, Larry A. McNichols, John D. Badzinski
-
Patent number: 7047069Abstract: A low cost, accurate, single use, disposable, iontophoretic fluid delivery device having cationic and anionic chambers separated by container structure and arranged to promote a flow of treatment ions into a body. The device desirably uses rugged minibatteries safely to provide increased electromotive force to the ion transfer process compared to galvanic cells having electrolyte matched to a human body's electrolyte. Minibatteries may be located in one or both cationic and anionic chambers, and/or attached to structure of a container outside the chambers. A shunt resistance may be arranged in a parallel circuit to the body to control delivery of a beneficial agent in any amount between 1 mAmp-min to 500 mAmp-min, or more. Substrates, located in the chambers and adapted to hold electrolyte or treatment drugs, may be electrically conductive to resist polarization of the chemicals near a conducting terminal.Type: GrantFiled: February 4, 2002Date of Patent: May 16, 2006Assignee: Ceramatec, Inc.Inventor: Ashok V. Joshi
-
Patent number: 7031769Abstract: An electrode assembly for use in an iontophoresis device for the transcutaneous administration of an active therapeutic species includes a base layer of conductive material which is consumed (oxidizes or reduces) preferentially to water, a first upper layer of sacrificial material coated on a first portion of the base layer wherein the sacrificial material is consumed preferentially to the conductive material of the base layer. A second upper layer of non-conducting material is coated on a second portion of the base layer, the second upper layer being spaced from the first upper layer, a narrow exposed linking area of the base layer material remaining therebetween. The exposed linking area of the base layer extends across the base layer. During operation of an associated iontophoresis device, the sacrificial material will be sequentially consumed; the first upper layer will be followed by the exposed linking area of the base layer which severs the base layer thereby breaking circuit continuity in the device.Type: GrantFiled: February 21, 2003Date of Patent: April 18, 2006Assignee: Birch Point Medical, Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Patent number: 7018370Abstract: The invention provides an improved electrotransport drug delivery system for analgesic drugs, namely fentanyl and sufentanil. The fentanyl/sufentanil is provided as a water soluble salt (e.g., fentanyl hydrochloride), preferably in a hydrogel formulation, for use in an electrotransport device (10). In accordance with the present invention, a transdermal electrotransport delivered dose of fentanyl/sufentanil is provided which is sufficient to induce analgesia in (e.g., adult) human patients suffering from moderate-to-severe pain associated with major surgical procedures.Type: GrantFiled: July 2, 2002Date of Patent: March 28, 2006Assignee: ALZA CorporationInventors: Mary Southam, Keith J. Bernstein, Henk Noorduin
-
Patent number: 7016724Abstract: An electrokinetic delivery system for personal use in self-administration of a medicament to a treatment site on an individual includes a device shaped to conform with the shape of a portion of an individual's finger from a tip thereof to a location past the first finger joint. A self-contained power source is carried by the device and a first electrode is carried by the device adjacent a distal end portion thereof and the tip of the individual's finger. The first electrode is in electrical contact with the power source. A second electrode is carried by the device for contact with the individual's finger. The second electrode is in electrical contact with the power source. Upon application of the first electrode over a treatment site with the medicament disposed between the first electrode and the treatment site and completion of an electrical circuit through the individual's body and said electrode, the device applies current for electrokinetically driving the medicament into the treatment site.Type: GrantFiled: December 1, 2003Date of Patent: March 21, 2006Assignee: Transport Pharmaceuticals, Inc.Inventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg
-
Patent number: 7011654Abstract: A dilating and support apparatus with disease inhibitors and methods for use is disclosed that is particularly useful for repairing and/or serving as a conduit for body passageways that require reinforcement, dilatation, disease prevention or the like. Such apparatuses are utilized to deliver a therapy, that therapy being from a family of devices, drugs, or any of a variety of other elements to a specific location within the body. The instant disclosure provides a system of combining a novel radial deployment and/or drug delivery therapy with existing balloon dilatation therapy into one device. This combination will yield a significant decrease in cost to the healthcare system as well as providing a therapy to the patient with increased safety and efficacy. Further, the instant invention provides a novel and improved platform for synthetic/tissue interface between the device and the body.Type: GrantFiled: February 12, 2001Date of Patent: March 14, 2006Assignee: Artemis Medical, Inc.Inventors: William Richard Dubrul, Richard E Fulton
-
Patent number: 6975902Abstract: A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.Type: GrantFiled: June 27, 2003Date of Patent: December 13, 2005Assignee: ALZA CorporationInventors: Joseph B. Phipps, Gary A. Lattin, Larry A. McNichols, John D. Badzinski
-
Patent number: 6972013Abstract: In vivo methods are provided for using an electric field to delivery therapeutic or immunizing treatment to a subject by applying non-invasive, user-friendly electrodes to the surface of the skin. Thus, therapeutic or immunizing agents can be delivered into cells of skin for local and systemic treatments or for immunization with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.Type: GrantFiled: August 30, 2002Date of Patent: December 6, 2005Assignee: Genetronics, Inc.Inventors: Lei Zhang, Dietmar P. Rabussay
-
Patent number: 6969382Abstract: A therapeutic device and therapeutic method for delivering electrical energy to a polymer containing a medicament that allows release of the medicament to a body tissue or organ. The device and method utilizes ultrasonic vibrations to cause the device, implanted in the body tissue or organ to be treated, to discharge an electrical current to the polymer containing the medicament. The medicament is controllably released to the target area by changing the charge of the polymer with the electrical current.Type: GrantFiled: January 21, 2003Date of Patent: November 29, 2005Assignee: Zuli Holdings, Ltd.Inventor: Jacob Richter
-
Patent number: 6918901Abstract: An agent delivery or sampling device (2) comprising a member (6) having a plurality of blades (4) for piercing the skin and a connecting medium (65) covering at least a part of the skin contacting side (48) of the member (6) for increasing transdermal flux of an agent.Type: GrantFiled: December 10, 1997Date of Patent: July 19, 2005Inventors: Felix Theeuwes, Michel J. N. Cormier, Armand P. Neukermans
-
Patent number: 6895271Abstract: Non-reusable, medicament-dispensing applicator electrodes adapted for use with an iontophoresis device for facilitating delivery of medication across the cutaneous membrane into adjacent underlying tissues and blood vessels. The embodiments of the iontophoresis electrode include an open mesh having cells in the medicament dispensing portions of the electrode which retain a medicament in the form of liquid, gel or ointment. The cells are adapted to contain and iontophoretically dispense and deliver medicament formulations, which have been previously approved for therapeutic use by cognizant regulatory authorities obviating the need for reformulation. The medicament-dispensing electrodes are composite or unitary in construction and may be useful in the treatment of acne and also genital herpes simplex infection which produces cutaneous lesions, including lesions above and below the waist.Type: GrantFiled: August 26, 2003Date of Patent: May 17, 2005Assignee: Biophoretic Therapeutic Systems, LLCInventor: Julian L. Henley
-
Patent number: 6881208Abstract: The invention provides an improved electrotransport drug delivery system for analgesic drugs, namely fentanyl and sufentanil. The fentanyl/sufentanil is provided as a water soluble salt (eg, fentanyl hydrochloride) dispersed in a hydrogel formulation for use in an electrotransport device (10). In accordance with one aspect of the invention, the concentration of fentanyl/sufentanil in the donor reservoir (26) solution is above a predetermined minimum concentration, whereby the transdermal electrotransport flux of fentanyl/sufentanil is maintained independent of the concentration of fentanyl/sufentanil in solution. In accordance with a second aspect of the present invention, the donor reservoir (26) of the electrotransport delivery device (10) is comprised of silver and the donor reservoir (26) contains a predetermined “excess” loading of fentanyl/sufentanil halide to prevent silver ion migration with attendant skin discoloration.Type: GrantFiled: June 5, 1995Date of Patent: April 19, 2005Inventors: Joseph B. Phipps, Mary Southam, Keith J. Bernstein, Henk Noorduin
-
Patent number: 6868286Abstract: The invention relates to a combination therapy by TTS and simultaneous initial ultrasound treatment and the subsequent use of the TTS without additional ultrasound treatment. The treatment is characterized in that it shows an effect without or with only little delay. This form of therapy is especially advantageous for treating strong or chronic pains. The invention relates to a corresponding device and the use of suitable pharmaceutical substances.Type: GrantFiled: October 23, 1999Date of Patent: March 15, 2005Assignee: LTS Lohmann Therapie-Systeme AGInventors: Thomas Hille, Bernhard Hehn
-
Publication number: 20040267236Abstract: The present invention features a device having a barrier membrane contacting surface, the device containing: a power source; a first conductive electrode; a second conductive electrode; a first light emitting diode; and a carrier containing an active agent; wherein the power source is in electric communication with the first conductive electrode, the second conductive electrode, and the light emitting diode, and wherein the device is arranged such that light from the first light emitting diode and the carrier are in communication with the barrier membrane contacting surface.Type: ApplicationFiled: June 30, 2003Publication date: December 30, 2004Inventors: Ying Sun, Jue-Chen Liu, Jeffrey M. Wu, Nikiforos Kollias
-
Publication number: 20040267237Abstract: The present invention features a method of treating acne or rosacea by applying to the skin electrochemically generated zinc ions. In one embodiment, the method includes topically applying a device including an anode containing zinc.Type: ApplicationFiled: October 14, 2003Publication date: December 30, 2004Inventors: Ying Sun, Jue-Chen Liu, Jeffrey M. Wu, James E. Hauschild
-
Patent number: 6795727Abstract: A non-invasive method of enhancing the permeability of the skin to a biologically active permeant or compound is described utilizing a combination of sonophoresis and chemical enhancers. Synergism brought simultaneously applying iontophoresis, electroporation, mechanical vibrations and magnetophoresis is used to optimize the transcutaneous active permeation of compounds, considerably lowering the time of treatment. The method is intended also for, among others, the non-invasive painless treatment of cellulitis, localized fat, stretch marks and flacid skin.Type: GrantFiled: October 17, 2001Date of Patent: September 21, 2004Inventor: Pedro Giammarusti
-
Patent number: 6792306Abstract: An electrokinetic delivery system for personal use in self-administration of a medicament to a treatment site on an individual includes a device shaped to conform with the shape of a portion of an individual's finger from a tip thereof to a location past the first finger joint. A self-contained power source is carried by the device and a first electrode is carried by the device adjacent a distal end portion thereof and the tip of the individual's finger. The first electrode is in electrical contact with the power source. A second electrode is carried by the device for contact with the individual's finger. The second electrode is in electrical contact with the power source.Type: GrantFiled: April 8, 2002Date of Patent: September 14, 2004Assignee: Biophoretic Therapeutic Systems, LLCInventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg
-
Publication number: 20040176737Abstract: An electrokinetic delivery or diagnostic device for personal use and self-administration of a medicament to a treatment site is provided. The device includes a housing containing a power supply, a first active electrode and a ground tactile electrode. An applicator includes a pad for containing medicament for overlying the first electrode of the device. The medicament may be applied by the user to the pad, contained within the pad or contained in rupturable capsules within the pad, together with a hydrogel if necessary for imparting electrical conductivity whereby, upon application of the applicator to the treatment site, the medicament is electrokinetically transported into the treatment site.Type: ApplicationFiled: March 24, 2004Publication date: September 9, 2004Applicant: Biophoretic Therapeutic Systems, LLCInventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg, Christopher H. Porter, V. Lorenzo Porcelli
-
Patent number: 6757560Abstract: A transdermal delivery system (TDS) having: a carrier layer (cover layer) impermeable to the substances/active ingredients to be delivered; a membrane permeable to the substances/active ingredients to be delivered; a reservoir containing substances/active ingredients to be delivered, the reservoir being provided between the carrier layer and the membrane; and a removable film, wherein each of the carrier layer and the membrane comprise one or more electrodes such that the electrode(s) of the membrane serve(s) as counter electrode(s) to die electrode (the electrodes) of the carrier layer, is disclosed.Type: GrantFiled: October 10, 2000Date of Patent: June 29, 2004Assignee: Novosis Pharma AGInventors: Wilfried Fischer, Ruediger Haas, Clifton Zimmermann
-
Patent number: 6738662Abstract: A portable, self-contained hand-held device for treating an illness or infection of tissue of a body is provided. The device comprises an integrally mounted metal ion source contactable with the tissue with an antimicrobial substance on at least a portion of the metal ion source. A conducting surface is contactable with the user. An automatically controlled and modulated field electrically is connected to the metal ion source and the conducting surface with the control system creating an electric field between the metal ion source and the conducting surface through the body wherein the antimicrobial substance is ionized upon application of the electric field thereby profusing the substance into the infected tissue. In another embodiment, a bandage is provided for adhering to the skin of the user.Type: GrantFiled: November 21, 2000Date of Patent: May 18, 2004Inventor: Steven R. Frank
-
Patent number: 6735470Abstract: An electrokinetic delivery or diagnostic device for personal use and self-administration of a medicament to a treatment site is provided. The device includes a housing containing a power supply, a first active electrode and a ground tactile electrode. An applicator includes a pad for containing medicament for overlying the first electrode of the device. The medicament may be applied by the user to the pad, contained within the pad or contained in rupturable capsules within the pad, together with a hydrogel if necessary for imparting electrical conductivity whereby, upon application of the applicator to the treatment site, the medicament is electrokinetically transported into the treatment site.Type: GrantFiled: September 18, 2002Date of Patent: May 11, 2004Assignee: BioPhoretic Therapeutic Systems, LLCInventors: Julian L. Henley, Kuo Wei Chang, Joseph Potter, Dennis I. Goldberg, Christopher H. Porter, V. Lorenzo Porcelli
-
Patent number: 6699282Abstract: An implanted device such as a stent is provided which is capable of holding an induced charge or sufficient magnitude that the device may, by electrostatic means, attract the bioactive material to itself. The charge, either positive or negative, or relative to the bioactive material sufficiently positive or negative, is deposited into the implantable device via an exterior induction coil. The implantable device itself becomes an introduced “dosage form”, becoming part of a biologically closed electric circuit, through which the bioactive material is attracted to the implanted device.Type: GrantFiled: March 6, 2003Date of Patent: March 2, 2004Assignee: Gelsus Research and Consulting, Inc.Inventor: Nicholas A. Sceusa
-
Patent number: 6678556Abstract: In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune response caused by the pulsed electric field. Therapeutic agents can be delivered nto cells of muscle for local and systemic treatments with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.Type: GrantFiled: June 7, 2002Date of Patent: January 13, 2004Assignee: Genetronics, Inc.Inventors: Edward Nolan, Dietmar P. Rabussay, Georg Widera, Lei Zhang
-
Patent number: 6678553Abstract: A device and methods are described for a non-invasive transnasal and transocular drug delivery to the central nervous system using iontophoresis technology. By delivered through the olfactory nerve and the optical nerve, a biologically active substance of interest can be enhanced to be delivered into the CNS and CSF and bypassing the blood-brain barrier. Such drug delivery system can also be enhanced by using phonophoresis and other enhancement techniques.Type: GrantFiled: May 20, 1998Date of Patent: January 13, 2004Assignee: Intraabrain International NVInventors: Eduard N. Lerner, Leonid Lerner
-
Publication number: 20040006328Abstract: Laser treatments of sebaceous gland disorders with laser sensitive dyes are disclosed. A preferred laser treatment includes topical application of an energy activatable material to the skin followed by laser irradiation.Type: ApplicationFiled: July 2, 2003Publication date: January 8, 2004Inventor: Richard Rox Anderson
-
Publication number: 20030233085Abstract: A non-invasive method of enhancing the permeability of the skin to a biologically active permeant or compound is described utilizing a combination of sonophoresis and chemical enhancers. The previous preparation of the skin using an ultrasonically generated mechanical skin scrubbing action is also described. Synergism brought simultaneously applying iontophoresis, electroporation, mechanical vibrations and magnetophoresis is used to optimize the transcutaneous active permeation of compounds, considerably lowering the time of treatment. The method is intended also for, among others, the non-invasive painless treatment of cellulitis, localized fat, stretch marks and flacid skin.Type: ApplicationFiled: June 18, 2002Publication date: December 18, 2003Inventor: Pedro Giammarusti
-
Patent number: 6662044Abstract: Patch-based devices for enhancing the local delivery of drugs, pharmaceuticals, plasmids, genes and other agents into the tissues of the living body. The patch devices provide an electrical driving force that can increase the rate of migration of drugs and other therapeutic agents out of a polymer matrix into body tissues and cells using iontophoresis only, electroporation only, or combined inontophoresis and electroporation. The two procedures may be applied sequentially in any order without removing or repositioning the patch.Type: GrantFiled: July 22, 2002Date of Patent: December 9, 2003Assignee: GMP Drug Delivery, Inc.Inventors: Neville Crawford, Charles L. Brown, III
-
Patent number: 6654635Abstract: An iontophoresis device, which can ensure the long-term stability of drugs and which can be easily assembled when used, is provided. A donor electrode-printed portion (6) is placed on one side of a backing layer (4), and a reference electrode-printed portion (7) is placed on the other side. Both printed parts are connected to a current generating part (Ia) through a connector (Id). A drug support film (14) is joined to a drug-dissolving portion (11), and a cup-like shaped protective cover (12), which covers the drug support film (14), is removed before the device is used. The exposed drug support film (14) is attached to the skin of a user, and the device is driven by turning on a power supply of the current-generating portion (Ia).Type: GrantFiled: August 24, 2000Date of Patent: November 25, 2003Assignee: Hisamitsu Pharmaceutical Co., Inc.Inventors: Nobuhiro Koga, Hiroyuki Maeda, Mitsuru Kuribayashi, Naruhito Higo
-
Patent number: 6654636Abstract: The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.Type: GrantFiled: July 26, 2000Date of Patent: November 25, 2003Assignee: Genetronics, Inc.Inventors: Nagendu B. Dev, Gunter A. Hofmann, Edward Nolan, Dietmar P. Rabussay, Arnt Tonnessen, Georg Widera, Lei Zhang
-
Patent number: 6635045Abstract: Provided is a method for loading electrode-corroding ingredients into an un-loaded donor gel reservoir of an electrode for an electrically assisted drug delivery system. The method provides that a salt, such as sodium chloride or an organic salt, is provided in the un-loaded donor gel reservoir, contrary to convention. Related electrically assisted drug delivery electrode assemblies also are provided.Type: GrantFiled: June 29, 2001Date of Patent: October 21, 2003Assignee: Vyteris, Inc.Inventors: Preston Keusch, Uday K. Jain, Vilambi Nrk Reddy, Bruce M. Eliash, Kevin John Carey, Vitaly Falevich
-
Publication number: 20030191426Abstract: A device to enhance the delivery of a drug or other substance of interest into a selected organ or tissue, comprising special electrodes, one of the electrodes carrying a container with the selected drug or other substance of interest, said electrodes being capable of being positioned at preselected locations of said organ or tissue, wherein the electrodes are all connected with a selected energy source which generates and maintains an energy field before and during the enhanced delivery of said substance, under the influence of which delivery is accomplished in a direction from the active to the passive electrode and into said organ or tissue. The energy source may be selected from suitable sources providing an electric field, a magnetic field, ultrasonic waves, high energy waves like laser beams, or a combination thereof.Type: ApplicationFiled: March 21, 2003Publication date: October 9, 2003Applicant: Intrabrain International NVInventors: Eduard N. Lerner, Leonid Lerner
-
Patent number: 6629968Abstract: A reservoir-electrode for an iontophoretic delivery device of the present invention includes an electrode; and a hydrophilic reservoir situated in electrically conductive relation to the electrode. The reservoir is formed from a bibulous hydrophilic cross-linked polymeric material having a substantially uniform concentration of an alkali metal chloride salt therein thereby substantially eliminating concentration gradients of the salt with respect to the electrode. The polymeric material has a first surface and a second surface that is adhesively adherent to the electrode. The first surface of the polymeric material is releasably adhesive to an applied area of a patient's skin.Type: GrantFiled: June 30, 2000Date of Patent: October 7, 2003Assignee: Vyteris, Inc.Inventors: Uday K. Jain, Vilambi N R K Reddy, Bruce M. Eliash, Kevin John Carey, Vitaly Falevich, Preston Keusch
-
Patent number: 6615078Abstract: This invention relates to methods for reducing the presence of a compound in an ionically conductive material, e.g., for use in iontophoretic devices, wherein the presence of the compound interferes with detecting a selected analyte. Removal of the compound can typically take place either during or after the manufacture of the ionically conductive material or an assembly comprising this material. Also disclosed are methods for generating selectively permeable barriers on the reactive faces of electrodes. Further, this invention relates to hydrogels comprising one or more biocides, as well as assemblies containing such hydrogels.Type: GrantFiled: April 21, 2000Date of Patent: September 2, 2003Assignee: Cygnus, Inc.Inventors: Kim K. Burson, Michelle Van Wyhe, Jeffrey Pudlo, Michael Reidy, Pravin Soni, Christopher Uhegbu, Prema Vijayakumar
-
Patent number: 6603998Abstract: An object of the invention is to provide a method for delivery of macromolecules into biological cells, such as Langerhans cells (22) in the epidermis (20) of a patient, which includes the steps of coating electodes (16) in an electrode assembly (12) with solid phase macromolecules to be delivered, such as a DNA, and/or RNA vaccine or a protein-based vaccine, attaching the electrode assembly (12) having the coated electrodes (16) to an electrode assembly holder (13), providing a waveform generator (15), establishing electrically conductive pathways between the electrodes (16), and the waveform generator (15), locating the electrodes (16) such that the biological cells are situated therebetween, such as by penetrating the needle electrode (16) into the epidermis (20) above the epidermal basal lamina, and providing pulse waveform from the waveform generator (15) to the electrodes (16), such that macromolecule on the electrodes (16) is driven off of the electrodes (16), and delivered into the biological cells, sType: GrantFiled: July 30, 2001Date of Patent: August 5, 2003Assignee: Cyto Pulse Sciences, Inc.Inventors: Alan D. King, Richard E. Walters
-
Patent number: 6600951Abstract: Laser treatments of sebaceous gland disorders with laser sensitive dyes are disclosed. A preferred laser treatment includes topical application of an energy activatable material to the skin followed by laser irradiation.Type: GrantFiled: December 16, 1999Date of Patent: July 29, 2003Assignee: The General Hospital CorporationInventor: Richard Rox Anderson
-
Patent number: 6595947Abstract: A method for delivering a substance to the epidermal tissue of skin. The method involves simultaneously disrupting only the stratum corneum of the skin and delivering the substance to the epidermal tissue of the skin.Type: GrantFiled: May 22, 2000Date of Patent: July 22, 2003Assignee: Becton, Dickinson and CompanyInventors: John A. Mikszta, John M. Brittingham, Jason Alarcon, Ronald J. Pettis, John P. Dekker, III
-
Patent number: 6582416Abstract: A method and apparatus for applying iontophoretic treatment to a biological subject wherein electrical treatment current between a pair of electrodes is periodically reversed at very low frequencies, substantially in the range of approximately 0.0027 Hz to approximately 10 Hz, to mitigate tissue damage, enable long term dosimetry with single and multiple drugs of any polarity and at higher concentrations, and eliminate the need for buffering agents and the like, all in a relatively simple, economical and compact physical packaging configuration. The system delivers treatment substances with large and/or small molecular size and weight and can be adjusted to control pH at the delivery site. A method of lowering resistance and enhancing permeability at the delivery site, as well as increasing drug concentrations and delivery rates.Type: GrantFiled: December 16, 1999Date of Patent: June 24, 2003Inventor: Robert Tapper
-
Patent number: 6579276Abstract: An ocular iontophoretic device for delivering an aptamer to an affected area of a living being's eye for inhibiting VEGF function therein, the device comprising an active electrode assembly associated with a matrix and/or reservoir, wherein the matrix and/or reservoir includes an aptamer capable of inhibiting VEGF function. A method for treating an affected area of a living being's eye, comprising the steps of: associating an aptamer with an ocular iontophoretic device; positioning at least a portion of an ocular iontophoretic device on the eye of the living being; and iontophoretically delivering the aptamer to an affected area of the living being's eye.Type: GrantFiled: January 22, 2001Date of Patent: June 17, 2003Assignee: Iomed, Inc.Inventors: Lindsay B. Lloyd, Thomas M. Parkinson, Malgorzata Szlek
-
Patent number: 6575957Abstract: A method and apparatus for applying iontophoretic treatment to a biological subject wherein electrical treatment current between a pair of electrodes is periodically reversed at very low frequencies, substantially in the range of approximately 0.0027 Hz to approximately 10 Hz, to mitigate tissue damage, enable long term dosimetry with single and multiple drugs of any polarity and at higher concentrations, and eliminate the need for buffering agents and the like, all in a relatively simple, economical and compact physical packaging configuration. The system delivers treatment substances with large and/or small molecular size and weight and can be adjusted to control pH at the delivery site. A method of lowering resistance and enhancing permeability at the delivery site, as well as increasing drug concentrations and delivery rates.Type: GrantFiled: November 8, 1993Date of Patent: June 10, 2003Inventor: Robert Tapper
-
Publication number: 20030100884Abstract: Treatment of pain syndromes utilizes a topical polypharmaceutical preparation of phenoxybenzamine, ketamine, gabapentin, nifedipine, carbamazepine, or combinations of them. Other suitable components are blockers of sympathetic alpha 1, 2 and other receptors, NMDA receptor blockers, GABA receptor blockers, AMPA receptor blockers, nitric oxide synthase receptor blockers, calcium channel blockers, ACDP receptor blockers, prostaglandin and leukotriene blockers, substance P blockers, bradykinin and neurotenin as well as other peptide blockers, and TNF alpha blockers. Recommended delivery is by locating a predetermined neurodermal point and locating a gel patch over the predetermined neurodermal point. Iontophoresis then delivers the pharmaceutical agent from the gel patch.Type: ApplicationFiled: November 26, 2001Publication date: May 29, 2003Inventor: William R. Deagle
-
Publication number: 20030097118Abstract: The present invention is based on the development of a method for cosmetic delivery of L-ascorbic acid-containing compositions to the layer of the skin wherein collagen formation takes place to enhance production of collagen and thereby combat some of the effects of aging and oxy-radical damage on skin. Sufficient electric pulses applied to a region of skin surface temporarily create new pathways through the lipid skin barrier, thereby delivering an L-ascorbic acid-containing composition through the lipid skin barrier and enhancing production of collagen in the region of the skin so treated. A handheld electrical pulser apparatus, optionally table-top adaptable, and methods of use for cosmetic treatment of degenerative skin conditions are provided by the invention.Type: ApplicationFiled: September 27, 2001Publication date: May 22, 2003Applicant: GENETRONICS, INC.Inventors: Lei Zhang, Gunter A. Hofmann
-
Publication number: 20030097090Abstract: Electroporation electrodes are laminated to a permeable membrane to form an electrode membrane. Such an electrode membrane is useful for a continuous controlled delivery of a therapeutic agent through the skin or mucosa, when placed in direct contact with the skin or mucosa and by application of electric field pulses at specified intervals. An electrode membrane can be assembled such that it incorporates an iontophoretic electrode in the same device. This device can be jointly utilized for electroporation and iontophoretic drug delivery through the skin and mucosal membrane.Type: ApplicationFiled: December 30, 2002Publication date: May 22, 2003Applicant: Hisamitsu Pharmaceutical Co., Inc.Inventors: Kenji Mori, Iwao Nozawa, Shuji Sato
-
Patent number: 6564093Abstract: A transdermal drug delivery system having at least one patch (20) with an electrosmotic, electro porous membrane (26) comprised of an inert biochemical substance which becomes actively electro-osmotic when an electric charge is passed through the membrane enabling a drug solution passing through to a skin surface to create an electroporative effect. The patch may be powered by a battery, an external power source (82), or self-powered by an auto-bio-fuel cell which acts as a battery during drug solution saturation. Multiple patches may be configured as a linked patch unit for use with a flexible cuff apparatus (70) to provide circumferential treatment of a body part. A network of supply tubes (66) may be connected to an external reservoir (68) to provide a slow supply of medicated fluid to each patch. A titration regulator (72) is in communication with the transdermal patch to regulate permanent flow to the skin.Type: GrantFiled: August 23, 2001Date of Patent: May 13, 2003Assignee: Electromagnetic Bracing Systems Inc.Inventors: Alvin Ostrow, Geert-Henk Koops, Joseph Tannenbaum
-
Patent number: 6560483Abstract: A patch for iontophoretic transdermal application of a medicant, where the patch includes a border portion disposed about an aperture. The border portion can include a first polarity electrode in electrical communication with the medicant, and a second border portion including a second electrode having a second polarity opposite the first electrode polarity. One patch has a liftable cover, preferably a transparent and non-adherent cover, disposed over the patch aperture. A preferred medicant for inclusion in the present invention is a local anesthetic or analgesic. Other medicants such as anti-inflammatory agents or anti-infective agents may be used to locally reduce inflammation, contain infection, and alleviate pain. The present invention can allow performing a field block anesthetic about an epidermal target site. The present invention can allow observing a target or treatment site while leaving the patch in place.Type: GrantFiled: October 18, 2000Date of Patent: May 6, 2003Assignee: Minnesota High-Tech Resources, LLCInventors: Matthew M. Kumar, Larry D. Johnson
-
Patent number: 6553253Abstract: An electrokinetic system for delivering a substance into tissue includes an alternating current source of a predetermined frequency. A first electrode is coupled to a first terminal of the alternating current source and a second electrode is coupled to a second terminal of the alternating current source. A rectifying circuit is coupled between the first electrode and the first terminal of the alternating current source. One of the first and second electrodes is adapted for electrical contact with a substance-delivery site. A current rectified by the rectifying circuit flows in a current path between the first and second electrodes when the one of the first and second electrodes is in electrical contact with the substance-delivery site to effect delivery of the substance into the tissue.Type: GrantFiled: March 10, 2000Date of Patent: April 22, 2003Assignee: Biophoretic Therapeutic Systems, LLCInventor: Kuo-Wei Chang
-
Patent number: 6553255Abstract: A device and method are provided that minimize the changes in flux encountered during iontophoresis and reduce inter-subject variability. For drug delivery, the active agent to be delivered is administered in conjunction with at least one background ion having a hindrance factor that changes at a faster rate than the hindrance factor of the active agent when an electrical current is applied. For analyte extraction, the extraction reservoir contains at least one background ion having a hindrance factor that changes at a faster rate than the hindrance factor of the background ions of the analyte in the tissue when an electrical current is applied.Type: GrantFiled: October 27, 2000Date of Patent: April 22, 2003Assignee: ACiont Inc.Inventors: David J. Miller, Kevin Li, William I. Higuchi
-
Patent number: 6547777Abstract: An apparatus, system, and method are provided for reducing interstitial fluid pressure in tissue, particularly in tumors. The apparatus includes an aspiration probe with at least one slit along its body to provide fluid communication between the aspiration probe and the tissue. Suction in the chamber of the aspiration probe generated by a suction source reduces the interstitial fluid pressure. Compared to prior art devices, the geometry of the slit of the aspiration probe is less likely to become blocked. The present invention also includes a cleaning obturator to unclog the slit and a blocking obturator to prevent accumulation of tissue in the aspiration probe chamber when suction is off. The blocking obturator can be made of a number of biocompatible materials, including a material impregnated with a pharmacological agent.Type: GrantFiled: February 16, 2001Date of Patent: April 15, 2003Assignee: Sloan-Kettering Institute for Cancer ResearchInventors: Gene R. DiResta, John Henry Healey
-
Patent number: RE38341Abstract: A portable iontophoresis apparatus for facilitating delivery of medication across the cutaneous membrane into adjacent underlying tissues and blood vessels. The apparatus employs a modular, detachable non-reusable medicament-containing applicator electrode which is adapted to attach to a base assembly. The apparatus is designed to be hand-held and includes a circumferential tactile electrode band on the base assembly which provides electrical connection between the skin of the user's hand and one pole of a bipolar power source housed within the base assembly. The opposing pole of the power source is connected to the applicator electrode. The user's body completes the electrical circuit between the applicator and tactile electrodes. A method for using the device for the treatment of Herpes simplex infection and related viral infections which produce similar cutaneous lesions is presented.Type: GrantFiled: December 27, 1999Date of Patent: December 9, 2003Assignee: Biophoretic Therapeutic Systems, LLCInventor: Julian L. Henley